ArticleJournal of medical Internet research2022
Chatbots for Smoking Cessation: Scoping Review.
Article in Journal of medical Internet research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Conversational Chatbot for Cigarette Smoking Cessation: Results From the 11-Step User-Centered Design Development Process and Randomized Controlled Trial.JMIR mHealth and uHealth · 2024Trial
- Use of the Dynamic Systems Development Method to Inform Technology-Assisted Motivational Interviewing (TAMI) for Tobacco Cessation: Qualitative Study.JMIR formative research · 2026Article
- Unlocking AI Chatbot Potential in Healthcare: Trust-Enhanced DeLone & McLean IS Success Model.Healthcare (Basel, Switzerland) · 2026Article
- The development and use of chatbots in enhancing health care access for underserved and vulnerable populations: a scoping review.BMC public health · 2025Article
- Perceptions of User-Generated Content as a Source of Health Messages in Smoking Cessation Mobile Interventions: Focus Group Study.JMIR human factors · 2025Article
- ChatGPT-Based Chatbot for Help Quitting Smoking via Text Messaging: An Interventional Study.JMIR formative research · 2025Article
- Assessing the Adherence of ChatGPT Chatbots to Public Health Guidelines for Smoking Cessation: Content Analysis.Journal of medical Internet research · 2025Article
- The role of chatbots and virtual assistants in enhancing tobacco cessation counselling.Frontiers in digital health · 2025Review
- Co-Designing a Smoking Cessation Chatbot: Focus Group Study of End Users and Smoking Cessation Professionals.JMIR human factors · 2024Article
- How Digital Solutions Might Provide a World of New Opportunities for Holistic and Empathic Support of Patients with Hidradenitis Suppurativa.Dermatology and therapy · 2024Article
- Introducing Quin: The Design and Development of a Prototype Chatbot to Support Smoking Cessation.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024Article
- Chatbots and COVID-19: Taking Stock of the Lessons Learned.Journal of medical Internet research · 2024Article
- Experts' views on translating NHS support to stop smoking in pregnancy into a comprehensive digital intervention.PLOS digital health · 2024Article
- A systematic review of chatbot-assisted interventions for substance use.Frontiers in psychiatry · 2024Article
- Chatbot-assisted therapy for patients with methamphetamine use disorder: a preliminary randomized controlled trial.Frontiers in psychiatry · 2023Article
- Conversational artificial intelligence interventions to support smoking cessation: A systematic review and meta-analysis.Digital healthReview
- Designing a just-in-time adaptive intervention with trigger detection and a generative chatbot: Smoking cessation use case.Digital healthArticle
- Smoking Cessation in Primary Care: A Narrative Review of Evidence-Based Treatment, Emerging Technology, and Harm Reduction Approaches.Journal of primary care & community healthReview
- Article
- AI chatbots for promoting healthy habits: Legal, ethical, and societal considerations.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite significant progress in reducing tobacco use over the past 2 decades, tobacco still kills over 8 million people every year. Digital interventions, such as text messaging, have been found to help people quit smoking. Chatbots, or conversational agents, are new digital tools that mimic instantaneous human conversation and therefore could extend the effectiveness of text messaging.
objectiveThis scoping review aims to assess the extent of research in the chatbot literature for smoking cessation and provide recommendations for future research in this area.
methodsRelevant studies were identified through searches conducted in Embase, MEDLINE, APA PsycINFO, Google Scholar, and Scopus, as well as additional searches on JMIR, Cochrane Library, Lancet Digital Health, and Digital Medicine. Studies were considered if they were conducted with tobacco smokers, were conducted between 2000 and 2021, were available in English, and included a chatbot intervention.
resultsOf 323 studies identified, 10 studies were included in the review (3 framework articles, 1 study protocol, 2 pilot studies, 2 trials, and 2 randomized controlled trials). Most studies noted some benefits related to smoking cessation and participant engagement; however, outcome measures varied considerably. The quality of the studies overall was low, with methodological issues and low follow-up rates.
conclusionsMore research is needed to make a firm conclusion about the efficacy of chatbots for smoking cessation. Researchers need to provide more in-depth descriptions of chatbot functionality, mode of delivery, and theoretical underpinnings. Consistency in language and terminology would also assist in reviews of what approaches work across the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.